Neoadjuvant Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer

被引：0
|
作者：
Kovtun, K. [1 ,2 ]
Moser, J. A. [1 ]
Callery, M. [1 ]
Kent, T. [1 ]
Tseng, J. [1 ]
Miksad, R. [1 ]
Bullock, A. [1 ]
Schlechter, B. [1 ]
Mahadevan, A. [1 ]
机构：
[1] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[2] Harvard Radiat Oncol Program, Boston, MA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2016年 / 96卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2016.06.1090
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2486
引用
收藏
页码：E198 / E198
页数：1
相关论文
共 50 条
  • [41] Neoadjuvant chemotherapy and radiotherapy outcomes in borderline-resectable and locally-advanced pancreatic cancer patients
    Botta, Gregory P.
    Huynh, Tridu R.
    Spierling-Bagsic, Samantha R.
    Agelidis, Alexander
    Schaffer, Randolph
    Lin, Ray
    Sigal, Darren
    CANCER MEDICINE, 2023, 12 (07): : 7713 - 7723
  • [42] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Attaallah, Wafi
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (28) : 3346 - +
  • [43] Neoadjuvant Stereotactic Body Radiation Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: Prognostic Factors for Local Recurrence and Survival
    Guss, Z. D.
    Rosati, L. M.
    Hsu, C. C.
    Hacker-Prietz, A.
    He, J.
    Pawlik, T. M.
    Makary, M. A.
    Hirose, K.
    De Jesus-Acosta, A.
    Le, D. T.
    Zheng, L.
    Laheru, D. A.
    Cameron, J. L.
    Wolfgang, C. L.
    Weiss, M. J.
    Herman, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : E212 - E213
  • [44] Concordance of Tumor Regression Grade After Neoadjuvant Therapy for Locally Advanced/Borderline Resectable Pancreatic Cancer (LA-PDAC)
    Matsuda, Yoko
    Kojima, Motohiro
    Fukumura, Yuki
    Hirabayashi, Kenichi
    Yamaguchi, Hiroshi
    Ishiwata, Toshiyuki
    Arai, Tomio
    Mino-Kenudson, Mari
    LABORATORY INVESTIGATION, 2018, 98 : 683 - 683
  • [45] CT Texture Analysis Effect of Neoadjuvant Stereotactic Body Radiation Therapy (SBRT) in Borderline Resectable and Locally Advanced Pancreatic Cancer
    Simoni, N.
    Micera, R.
    De Robertis, R.
    D'Onofrio, M.
    Rossi, G.
    Cardobi, N.
    Capelli, P.
    Paiella, S.
    Montemezzi, S.
    Mazzarotto, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E782 - E782
  • [46] Concordance of Tumor Regression Grade After Neoadjuvant Therapy for Locally Advanced/Borderline Resectable Pancreatic Cancer (LA-PDAC)
    Matsuda, Yoko
    Kojima, Motohiro
    Fukumura, Yuki
    Hirabayashi, Kenichi
    Yamaguchi, Hiroshi
    Ishiwata, Toshiyuki
    Arai, Tomio
    Mino-Kenudson, Mari
    MODERN PATHOLOGY, 2018, 31 : 683 - 683
  • [47] Neoadjuvant Chemoradiotherapy for Resectable and Borderline Resectable Pancreatic Cancer
    Hayakawa, S.
    Karasawa, K.
    Fujisawa, T.
    Ito, K.
    Shibata, Y.
    Shimizuguchi, T.
    Nihei, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E236 - E236
  • [48] Neoadjuvant FOLFIRINOX Combined with Aggressive Surgical Resection Allows Potentially Curative Therapy for Borderline Resectable and Locally Advanced Pancreatic Cancer
    Bloom-Ston, M.
    Blazer, M.
    Onesti, J.
    Schmidt, C. R.
    Muscarella, P.
    Bekaii-Saab, T.
    ANNALS OF SURGICAL ONCOLOGY, 2014, 21 : S37 - S37
  • [49] Neoadjuvant therapy in resectable and borderline pancreatic adenocarcinomas
    Perez Casanova, L.
    Serrano, T.
    Fabregat, J.
    Valls, C.
    Laquente, B.
    Condom, E.
    VIRCHOWS ARCHIV, 2014, 465 : S311 - S311
  • [50] Current status and future perspective of neoadjuvant therapy in locally advanced and borderline resectable pancreatic adenocarcinoma: a narrative review
    Hyung, Jaewon
    Lee, Sang Soo
    Hwang, Dae Wook
    Park, Jin-Hong
    Kim, Kyu-Pyo
    Yoo, Changhoon
    CHINESE CLINICAL ONCOLOGY, 2022, 11 (03)
12345